Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey W McCaughan

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
JAMA|February 17, 2012
Cancer risk after organ transplantationClaire M Vajdic, Geoffrey W McCaughan, Andrew E Grulich
Expert Review of Gastroenterology & Hepatology|March 21, 2017
An update on the pathophysiology and management of polycystic liver diseaseMay Yw Wong, Geoffrey W McCaughan, Simone I Strasser
Hospital Medicine (London, England : 1998)|February 3, 2005
Liver transplantation for viral hepatitisGeoffrey W McCaughan, David J Koorey, Simone I Strasser
Hepatology (Baltimore, Md.)|May 30, 2008
Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signalingNicholas A Shackel, Geoffrey W McCaughan, Fiona J Warner
Frontiers in Immunology|October 5, 2020
Induction Phase of Spontaneous Liver Transplant ToleranceGeoffrey W McCaughan, David G Bowen, Patrick J Bertolino
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 29, 2025
Potential missed opportunities to improve long-term liver allograft healthMohammad Amin Fallahzadeh, Geoffrey W McCaughan, Jacqueline G O'Leary
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2004
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infectionAmany Zekry, Margret Gleeson, Seren Guney, et al.
Hepatology (Baltimore, Md.)|November 1, 2011
The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infectionMark D Gorrell, Amany Zekry, Geoffrey W McCaughan, et al.
Hepatology International|November 14, 2020
Current perspectives on the tumor microenvironment in hepatocellular carcinomaCositha Santhakumar, Edward J Gane, Ken Liu, et al.
Expert Review of Gastroenterology & Hepatology|August 29, 2014
Is there such a thing as protocol immunosuppression in liver transplantation?Geoffrey W McCaughan, Kenny Ching Pan Sze, Simone I Strasser
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
JAMA|February 17, 2012
Cancer risk after organ transplantationClaire M Vajdic, Geoffrey W McCaughan, Andrew E Grulich
Expert Review of Gastroenterology & Hepatology|March 21, 2017
An update on the pathophysiology and management of polycystic liver diseaseMay Yw Wong, Geoffrey W McCaughan, Simone I Strasser
Hospital Medicine (London, England : 1998)|February 3, 2005
Liver transplantation for viral hepatitisGeoffrey W McCaughan, David J Koorey, Simone I Strasser
Hepatology (Baltimore, Md.)|May 30, 2008
Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signalingNicholas A Shackel, Geoffrey W McCaughan, Fiona J Warner
Frontiers in Immunology|October 5, 2020
Induction Phase of Spontaneous Liver Transplant ToleranceGeoffrey W McCaughan, David G Bowen, Patrick J Bertolino
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 29, 2025
Potential missed opportunities to improve long-term liver allograft healthMohammad Amin Fallahzadeh, Geoffrey W McCaughan, Jacqueline G O'Leary
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2004
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infectionAmany Zekry, Margret Gleeson, Seren Guney, et al.
Hepatology (Baltimore, Md.)|November 1, 2011
The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infectionMark D Gorrell, Amany Zekry, Geoffrey W McCaughan, et al.
Hepatology International|November 14, 2020
Current perspectives on the tumor microenvironment in hepatocellular carcinomaCositha Santhakumar, Edward J Gane, Ken Liu, et al.
Expert Review of Gastroenterology & Hepatology|August 29, 2014
Is there such a thing as protocol immunosuppression in liver transplantation?Geoffrey W McCaughan, Kenny Ching Pan Sze, Simone I Strasser
Pageof 26